BRCA1 and prostate carcinoma: It was not possible to compare the risk of other tumors typically associated with pathogenic BRCA1/2 variants (particularly pancreatic and prostate cancers) associated with the c.5017_5019del (p.His1673del) variant with that conferred by other BRCA1/2 variants because of the limited number of cases with such tumors in this series.